+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Homeostatic Model Assessment of Insulin Resistance for Predicting the Recurrence of Hepatocellular Carcinoma after Curative Treatment



Homeostatic Model Assessment of Insulin Resistance for Predicting the Recurrence of Hepatocellular Carcinoma after Curative Treatment



International Journal of Molecular Sciences 20(3)



Diabetes mellitus (DM) is a risk factor for hepatocellular carcinoma (HCC). The purpose of this study was to investigate the impact of the disorder of glucose metabolism on the recurrence of HCC after curative treatment. Two hundred and eleven patients with HCC who received curative treatment in our hospital from 2006 to 2017 were enrolled in this study. Recurrence-free survival was estimated using the Kaplan⁻Meier method, and the differences between the groups partitioned by the presence or absence of DM and the values of hemoglobin A1c (HbA1c), fasting plasma glucose (FPG), fasting immunoreactive insulin (FIRI), and homeostasis model assessment-insulin resistance (HOMA-IR) were evaluated using the log-rank test. There were no significant differences in the recurrence-free survival rate between the patients with and without DM (p = 0.144), higher and lower levels of HbA1c (≥6.5 and <6.5%, respectively; p = 0.509), FPG (≥126 and <126 mg/dL, respectively; p = 0.143), and FIRI (≥10 and <10 μU/mL, respectively; p = 0.248). However, the higher HOMA-IR group (≥2.3) had HCC recurrence significantly earlier than the lower HOMA-IR group (<2.3, p = 0.013). Moreover, there was a significant difference between the higher and lower HOMA-IR groups without DM (p = 0.009), and there was no significant difference between those groups with DM (p = 0.759). A higher HOMA-IR level, particularly in non-diabetic patients, was a significant predictor for HCC recurrence after curative treatment.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066446275

Download citation: RISBibTeXText

PMID: 30704150

DOI: 10.3390/ijms20030605


Related references

Highly sensitive AFP-L3% assay is useful for predicting recurrence of hepatocellular carcinoma after curative treatment pre- and postoperatively. Hepatology Research 41(11): 1036-1045, 2011

A prognostic model and treatment strategy for intrahepatic recurrence of hepatocellular carcinoma after curative resection. World Journal of Surgery 35(1): 170-177, 2011

Insulin resistance raises the risk for recurrence of stage I hepatocellular carcinoma after curative radiofrequency ablation in hepatitis C virus-positive patients: A prospective, case series study. Hepatology Research 40(4): 376-382, 2010

Adjuvant interferon for early or late recurrence of hepatocellular carcinoma and mortality from hepatocellular carcinoma following curative treatment: A meta-analysis with comparison of different types of hepatitis. Molecular and Clinical Oncology 2(6): 1125-1134, 2014

Histological Sub-classification of Cirrhosis Is Useful for Predicting Recurrence and Survival After Curative Resection of HBV-related Hepatocellular Carcinoma. Clinical Gastroenterology and Hepatology 12(1): 156-157, 2014

Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 14(2): 178-185, 2015

Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma. Hepatobiliary and Pancreatic Diseases International 14(2): 178-185, 2016

Appropriate treatment strategies for intrahepatic recurrence after curative resection of hepatocellular carcinoma initially within the Milan criteria: according to the recurrence pattern. European Journal of Gastroenterology and Hepatology 27(8): 933-940, 2016

Homeostatic Model Assessment for Insulin Resistance (HOMA-IR): A Better Marker for Evaluating Insulin Resistance Than Fasting Insulin in Women with Polycystic Ovarian Syndrome. Journal of the College of Physicians and Surgeons--Pakistan 27(3): 123-126, 2018

A new prognostic model for hepatocellular carcinoma recurrence after curative hepatectomy. Oncology Letters 15(4): 4411-4422, 2018

Analysis of prognostic factors affecting survival after initial recurrence and treatment efficacy for recurrence in patients undergoing potentially curative hepatectomy for hepatocellular carcinoma. Annals of Surgical Oncology 14(8): 2337-2347, 2007

Prevention of recurrence after curative treatment for hepatocellular carcinoma. Surgery Today 43(12): 1347-1354, 2014

Failure of homeostatic model assessment of insulin resistance to detect marked diet-induced insulin resistance in dogs. Diabetes 63(6): 1914-1919, 2014

Sarcopenia is a risk factor for the recurrence of hepatocellular carcinoma after curative treatment. Hepatology Research 46(2): 201-208, 2015

Appropriate treatment strategy for intrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma. Journal of Gastrointestinal Surgery 15(7): 1182-1187, 2011